Mwandishi:
Mhariri:
Imeboershwa:
ULY CLINIC
ULY CLINIC
17 Februari 2026, 14:31:27
Lichen Planus
Lichen planus is a chronic immune-mediated inflammatory disorder affecting the skin, mucous membranes, hair follicles, and nails. It is characterized by intensely pruritic violaceous papules and plaques and may follow a prolonged relapsing course.
The disease is mediated by T-cell–driven autoimmune attack against basal keratinocytes, leading to destruction of the epidermal basal layer.
It commonly affects adults between 30–60 years, and may be associated with certain medications, infections (notably hepatitis C), and stress.
Etiology and Risk Factors
Idiopathic (most common)
Exact cause unknown
Drug-induced (Lichenoid drug eruption)
Common triggers include:
Antimalarials
Thiazide diuretics
NSAIDs
Beta-blockers
ACE inhibitors
Gold salts
Associated Conditions
Hepatitis C infection
Autoimmune diseases
Psychological stress
Dental amalgam reactions (oral lichen planus)
Pathophysiology
Cytotoxic CD8+ T-cells attack basal keratinocytes
Degeneration of basal cell layer occurs
Hyperkeratosis develops
Leads to characteristic purple polygonal papules
Classic description:“6 Ps” of Lichen Planus
Pruritic
Purple
Polygonal
Planar
Papules
Plaques
Clinical Features
Cutaneous Lichen Planus
Violaceous shiny flat-topped papules
Fine white lines (Wickham striae)
Lesions coalesce into plaques
Extremely itchy
Distribution
Flexor wrists
Forearms
Inner thighs
Sacral area
Ankles
Post-Inflammatory Changes
Hyperpigmentation common (especially darker skin)
Oral Lichen Planus
Reticular white lacy patches
Painful erosions
Burning sensation with spicy food
Hair Involvement (Lichen Planopilaris)
Patchy hair loss
Permanent scarring alopecia
Nail Involvement
Longitudinal ridging
Thinning
Pterygium formation
Nail loss (severe cases)
Signs & Symptoms
Violaceous shiny flat-topped papules
Coalescing scaly plaques
Severe itching
Distribution on inner wrists, arms, thighs and sacral area
Post-inflammatory hyperpigmentation
Possible scarring alopecia (lichen planopilaris)
Diagnostic Criteria
Clinical diagnosis based on:
Classic purple polygonal papules
Flexural distribution
Intense pruritus
Post-inflammatory pigmentation
Possible hair follicle destruction
Skin biopsy confirms diagnosis if uncertain.
Investigations
Usually clinical diagnosis, but may include:
Skin biopsy (saw-tooth lymphocytic infiltrate)
Hepatitis C screening
Liver function tests
Direct immunofluorescence (if atypical)
For oral lesions:
Biopsy to rule out malignancy in chronic erosive disease
Treatment
Treatment aims to relieve itching, suppress inflammation, and prevent scarring.
Non-Pharmacological Treatment
Avoid scratching
Stress reduction
Avoid triggering drugs
Gentle skin care
Avoid irritating soaps
Maintain oral hygiene (oral LP)
Avoid spicy or acidic foods (oral involvement)
Pharmacological Treatment
Mild to Moderate Disease
Chlorpheniramine 4 mg orally every 6 hours for 2 weeks
AND
Betamethasone valerate ointment 0.1% twice daily for 2–4 weeks
OR
Clobetasol propionate ointment 0.05%–0.1% twice daily for 2–4 weeks
Severe Disease
Refer to specialist for:
Systemic corticosteroids
Occlusive topical steroid therapy
Retinoids
Phototherapy
Oral Lichen Planus (Painful)
Topical high potency steroid gel
Topical anesthetic mouthwash
Complications
Persistent hyperpigmentation
Permanent scarring alopecia
Nail dystrophy
Secondary infection
Squamous cell carcinoma (rare, oral erosive type)
Prognosis
Cutaneous disease: resolves within 1–2 years in many patients
Oral disease: chronic and recurrent
Pigmentation may persist long after lesions heal
Prevention
Avoid triggering medications
Early treatment of lesions
Manage stress
Regular follow-up for oral lesions
Good skin and oral hygiene
References
Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 7th ed. Dodoma: MoH; 2023.
Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. Elsevier; 2018.
James WD, Elston DM, Treat JR, Rosenbach MA. Andrews’ Diseases of the Skin: Clinical Dermatology. 13th ed. Elsevier; 2020.
Le Cleach L, Chosidow O. Lichen planus. N Engl J Med. 2012;366:723-732.
World Health Organization. WHO Model Formulary 2023. Geneva: WHO; 2023.
Imeandikwa;
3 Novemba 2020, 12:29:22
